尊龙凯时人生就是搏·(中国区)官方网站

CONNECTED TRANSACTION IN RELATION TO (1) ACQUISITION OF 29.99% EQUITY INTEREST IN THE TARGET COMPANY; AND (2) POSSIBLE VOLUNTARY PARTIAL OFFER TO ACQUIRE A MAXIMUM OF 25.01% EQUITY INTEREST IN THE TARGET COMPANY

VOLUNTARY DISCLOSURE - 2024 THIRD QUARTER UPDATE

VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW INDICATION APPLICATION FOR MARKETING OF ANLOTINIB HYDROCHLORIDE CAPSULES IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF ADVANCED SOFT TISSUE SARCOMA

VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY CHIA TAI TIANQING UNDER THE SHARE INCENTIVE SCHEME

VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY CHIA TAI TIANQING UNDER THE SHARE INCENTIVE SCHEME

VOLUNTARY ANNOUNCEMENT - SIGNING OF AN EXCLUSIVE LICENSE AND COOPERATION AGREEMENT WITH YZY BIOPHARMA

VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME

VOLUNTARY ANNOUNCEMENT - PROGRESS UPDATE ON THE "IMPLEMENTATION OF SHARE INCENTIVE SCHEME BY CHIA TAI TIANQING"